BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics

Core Viewpoint - Faruqi & Faruqi, LLP has initiated an investigation into Beta Bionics, Inc. following a significant decline in its stock price due to disappointing preliminary fourth-quarter performance metrics [1] Group 1: Company Performance - Beta Bionics reported lower-than-expected new patient starts for its iLet automated insulin delivery system, raising concerns about near-term adoption trends and revenue growth [1] - On January 9, 2026, Beta Bionics' stock fell approximately $11.85, or 37.04%, closing at $20.14 [1] Group 2: Legal Actions - Faruqi & Faruqi, LLP is encouraging investors who suffered significant losses in Beta Bionics stock or options to discuss their legal rights [1] - The law firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [1]